Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-Siglec-7 antibodies for the treatment of cancer

Anti-Siglec-7 antibodies for the treatment of cancer

US Patent 11773162 · Granted Oct 3, 2023

Estimated economic value: $3,428,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD38 binding domains2025
Anti-CD38 antibodies2025
Anti-Dectin-1 antibodies and methods of use thereof2024
Anti-Siglec-7 antibodies having reduced effector function2024
Anti-Siglec-7 antibodies having reduced effector function2024
Anti-Siglec-7 antibodies having reduced effector function2024
Anti-CD94 antibodies and methods of use thereof2023
Anti-CD38 antibodies2022
Anti-CD38 binding domains2022
Methods and compositions for treating perennial allergic conjunctivitis and kera2021
Methods and compositions for treating perennial allergic conjunctivitis and kera2021
Fusions of antibodies to CD38 and attenuated interferon alpha2021